New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
08:21 EDTAFFX, SQNM, FLDM, PKI, DDXS, WAT, PACBMaxim recommends life science tools, diagnostics ahead of earnings
Maxim expects 2014 to be a "great year" for life science tools and diagnostics stocks and recommends buying Affymetrix (AFFX), diaDexus (DDXS), Fluidigm (FLDM), Pacific Biosciences (PACB), PerkinElmer (PKI), Sequenom (SQNM) and Waters (WAT) ahead of the Q4 results. Maxim has a preference for Pacific Biosciences, PerkinElmer and Waters. The firm raised its price target for Fluidigm to $52 from $42 and for Pacific Biosciences to $9 from $8.
Sign up for a free trial to see the rest of the stories you've been missing.
November 30, 2015
08:36 EDTWATWaters open subsidiaries in Malaysia
Waters Corporation announced the opening of a new office in Kuala Lumpur, Malaysia, to more effectively supply all Waters products and services to customers directly. "Due to the dynamic development of the analytical instrument business in Malaysia, Waters is delighted to extend our support to our expanding customer base by establishing direct in-country operations. Speaking on behalf of all new Waters employees in Malaysia, we are extremely excited to take our sales and service capabilities to new levels," said Mathieu Laouenan, General Manager of South East Asia & Australia, Waters Division.
07:44 EDTPKIRadiological Society of North America to hold annual meeting
Subscribe for More Information
November 17, 2015
08:04 EDTWATStifel to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use